{"title":"关于抗癌纳米机器人","authors":"A. Fymat","doi":"10.15406/jcpcr.2018.09.00363","DOIUrl":null,"url":null,"abstract":"There have recently been two major developments and advances in this field, namely1 the construction of an autonomous DNA nanorobot as an intelligent drug delivery and therapeutic system that responds to molecular triggers in vivo and2 the successful programming of autonomous nanorobots to shrink tumors by cutting-off their blood supply (an antiangiogenic approach, see Fymat).3 The structures are built from DNA that can self-fold in all sorts of shapes and sizes.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"43 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"On cancer-fighting nanorobots\",\"authors\":\"A. Fymat\",\"doi\":\"10.15406/jcpcr.2018.09.00363\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"There have recently been two major developments and advances in this field, namely1 the construction of an autonomous DNA nanorobot as an intelligent drug delivery and therapeutic system that responds to molecular triggers in vivo and2 the successful programming of autonomous nanorobots to shrink tumors by cutting-off their blood supply (an antiangiogenic approach, see Fymat).3 The structures are built from DNA that can self-fold in all sorts of shapes and sizes.\",\"PeriodicalId\":15185,\"journal\":{\"name\":\"Journal of Cancer Prevention & Current Research\",\"volume\":\"43 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer Prevention & Current Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/jcpcr.2018.09.00363\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Prevention & Current Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jcpcr.2018.09.00363","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
There have recently been two major developments and advances in this field, namely1 the construction of an autonomous DNA nanorobot as an intelligent drug delivery and therapeutic system that responds to molecular triggers in vivo and2 the successful programming of autonomous nanorobots to shrink tumors by cutting-off their blood supply (an antiangiogenic approach, see Fymat).3 The structures are built from DNA that can self-fold in all sorts of shapes and sizes.